CompoAtlas

EVOPTOGEN

Food supplement declared in France, declaration No 2022-12-26

EVOPTOGEN (HSN) is a food supplement declared in France. Status: retiré du marché le 12 March 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
HSN
Food business operator placing the product on the market
HARRISON SPORT NUTRITION, S.L.
Status
Retiré du marché le 12 March 2026
Form
Capsule
Daily dose
1 cápsule
Directions for use
Prendre 1 capsule végétale, 1 fois par jour.
Not recommended for (according to the manufacturer)
Sous anticoagulants

Declaration 190008, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Sedum roseum (L.) Scop.RacineExtrait sec hydroalcoolique200 mg
Eleutherococcus senticosus (Rupr. et Maxim.) MaximRacineExtrait sec hydroalcoolique150 mg
Withania somnifera (L.) DunalFeuilleExtrait sec hydroalcoolique120 mg
Schisandra chinensis (Turcz.) Baill.BaieExtrait fluide hydroalcoolique50 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide nicotiniqueAcide nicotinique (vitamine B3)10 mg8 mg
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E464, E470b, E552

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

' emploi chez les personnes sous traitement anti-coagulant est déconseillé. De manière générale, il est recommandé d’inviter les femmes enceintes et allaitantes à prendre l’attache d’un professionnel de santé avant toute complémentation.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : HSN

Enter to analyse, Shift+Enter for a new line